2Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009[J].CA Cancer J Clin,2009,59(4) : 225-249.
3Althuis MD, Dozier JM, Anderson WF, et al. Global trends in breast cancer incidence and mortality 1973-1997[J]. Int J Epidemiol, 2005, 34(2), 405- 412.
4McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors and genetics[J]. BMJ, 1994, 309 (6960) : 1003-1006.
5Rosen PP, Groshen S, Kinne DW, et al. Factors influencing progno sis in node-negative breast carcinoma: analysis of 767 T1NOM0/ T2N0M0 patients with long-term follow up[J]. J Clin Oncol, 1993, 11(11) : 2090-2100.
6Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999[J]. Arch Pathol Lab Med, 2000, 124(7) : 966-978.
7Coyle YM, Xie XJ, Hardy DB, et al. Progesterone receptor expression is a marker for early stage breast cancer: implications for progesterone receptor as a therapeutic tool and target[J]. Cancer Lett, 2007, 258(2): 253-261.
8Quenel N, Wafflart J, Bonichon F, et al. The prognostic value of cerbB2 in primary breast carcinomas: a study on 942 cases[J]. Breast Cancer Res Treat, 1995, 35(3) : 283- 291.
9XiongQ, ValeroV, KauV, etal. Female patients with breast cardnomaage 30 years and younger have a poor prognosis, the M.D. Anderson Cancer Center expenenee[J]. Cancer, 2001, 92 (10) 2523-2528.
10Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: international consensus panel on the treatment of primary breast cancer [J]. J Natl Cancer Inst, 1998, 90(21) : 1601-1608.
